Inspiro s.r.o.
- Address
- Ul. 1.Maja 6205/25, 066 01 Humenné, Slovakia
Inspiro s.r.o. - Advanced Respiratory Disease Research Center
Inspiro s.r.o. is a specialized clinical research facility with extensive expertise in respiratory medicine, particularly focusing on chronic obstructive pulmonary disease and related respiratory conditions. The center demonstrates significant capabilities in conducting Phase 3 clinical trials and long-term extension studies, evaluating novel biologic therapies and small molecule interventions for complex respiratory disorders.
- Chronic Obstructive Pulmonary Disease (COPD) therapeutics including biologics (itepekimab, tezepelumab, verekitug) and add-on maintenance therapies
- COPD exacerbation prevention and disease control studies in moderate to very severe patient populations
- Refractory and unexplained chronic cough management with novel P2X3 receptor antagonists
- Long-term safety and tolerability assessments for respiratory biologics
The center has particular strength in evaluating biologic monoclonal antibodies targeting inflammatory pathways in COPD, including anti-IL-33 and TSLP-targeting agents. Their research portfolio includes investigations of triple therapy combinations with ICS, LABA, and LAMA, as well as studies specifically designed for former smokers with moderate-to-severe disease. Inspiro s.r.o. maintains robust capabilities in monitoring acute exacerbation rates and conducting comprehensive safety evaluations for respiratory therapeutics.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Inspiro s.r.o.
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab in adult participants with COPD with Type 2 inflammation. | Glaxosmithkline Research & Development Limited | Phase III | Recruiting | Jan 2026 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Itepekimab | 2 | Unknown | 2021-03-22 | 2024-05-15 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.